Peter Haan Johnson MD

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Medical Oncologist/Hematologist

13111 N Port Washington RdMequon, WI 53097
Phone+1 262-243-7454

Dr. Johnson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Johnson's full profile Already have an account?

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2001 - 2004
University of Kentucky College of MedicineClass of 2001
Princeton UniversityB.A., Ecology and Evolutionary Biology, 1993 - 1997

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

WI State Medical License 2006 - 2027
TX State Medical License 2004 - 2007
MA State Medical License 2003 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2017

Publications & Presentations

PubMed

3 citations
The use of HER2 modulation in the adjuvant setting.
Peter H. Johnson, Francisco J. Esteva
Current Oncology Reports. 2007-01-01
243 citations
Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero
Karin M. E. Hahn, Peter H. Johnson, Nancy Gordon, Henry Mark Kuerer, Lavinia P. Middleton
Cancer. 2006-09-15

Journal Articles

Vorinostat and Bortezomib as Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study
Tien Hoang, Toby C. Campbell, Chong Zhang, KyungMann Kim, Jill M. Kolesar, Kurt R. Oettel, Jules H. Blank, Emily G. Robinson, Harish G. Ahuja, Ron J. Kirschling, Peter..., Investigational New Drugs, 6/1/2013
The Use of HER2 Modulation in the Adjuvant Setting
Peter H. Johnson and Francisco J. Esteva, Current Oncology Reports, 1/1/2007
Update on Approaches to the treatment of non-small-cell lung cancer
P.H. Johnson and E.S. Kim, Oncology, 1/1/2005

Abstracts/Posters

Nuclear staining of topoisomerase II (topo II) may predict response to anthracycline but not to taxane based neoadjuvant chemotherapy regimens.
Peter Johnson, Savitri Krishnamurthy, Aman Buzdar, Gabriel Hortobagyi, Stacy Moulder, Breast Cancer Research and Treatment, 12/1/2006
The Treatment of Pregnant Women with Breast Cancer and the Outcomes of the Children Exposed to Chemotherapy In Utero.
P. Johnson, K.Gwyn, N. Gordon, L. Middleton, H. Kuerer, G. Perkins, W. Yang, G. Hortobagyi, R. Theriault, Journal of Clinical Oncology; 2005 Meeting of the American Society of Clinical Oncology, 1/1/2005

Press Mentions

COVID-19 Vaccination May Offer Less Effective and Shorter-Lasting Protection for Some Cancer PatientsJune 7th, 2022
Your Guide to the Top Doctors in the Milwaukee AreaJune 1st, 2022
Population-Scale Study Highlights Ongoing Risk of COVID-19 in Some Cancer Patients Despite VaccinationMay 24th, 2022